NCT04613726View on ClinicalTrials.gov

The Effect of Intravenous Granisetron and Ondansetron in Patients Undergoing Cesarean Section

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 3, 2018

Primary Completion Date

December 12, 2019

Study Completion Date

January 1, 2020

Conditions
Vomiting, PostoperativePostoperative ComplicationsHypotension
Interventions
DRUG

ondansetron

group consisted of receiving IV 8 mg ondansetron diluted in 10 ml of normal saline

DRUG

Granisetron

Another comparator group consisted of receivingIV 3 mg granisetron diluted in 10 ml of normal saline

DRUG

Saline

Control group consisted of patients receiving IV 10 ml normal saline

Trial Locations (1)

25240

Mehmet AKSOY, Erzurum

All Listed Sponsors
lead

Ataturk University

OTHER

NCT04613726 - The Effect of Intravenous Granisetron and Ondansetron in Patients Undergoing Cesarean Section | Biotech Hunter | Biotech Hunter